流式细胞术应用于抗肿瘤药物敏感性实验的可行性研究

摘要

Objective:To investigate the feasibility of chemosensitivity testing of antitumor drugs by flow cytometry in clinical applications so as to provide experimental and theoretical basis for the establishment of a novel antitumor drugs sensitivity testing and the screening of particular antitumor drugs.Methods:Detect the apoptosis rate of 12 cases of Molt-4 cell line.57 cases of fresh clinical gastrointestinal tumor cells by Sub-G1 and Annexin V assay of flow cytometry under the effects of antitumor drugs at different times and the outcomes were compared with the ones of the MTT(3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide)assay.Results:The lethality of drugs on Molt-4 cell clinica gastrointestinal tumor cells had a positive correlation with the acting time of antidrugs by employing Annexin V.Sub-G1 and MTT assay.Drug-incurring maximum lethality of Annexin V assay was higher than MTT colorimetric assay.that of Sub-G1 was lower than MTT assay.the virtual times of Annexin V and Sub-G1 assay were obviously earlier than that of MTT colorimetric assay.Conclusion:Annexin V and Sub-G1 assay of flow cytometry can be taken as potent protocols testing anti-tumor drug chemosensitivity.Annexin V assay is featured by more sensitive,concise,reliable compared with the classical chemosensilivity testing assay Of MTT colorimetric assay and it possesses clinical applied value.